Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Human Vaccines & Immunotherapeutics|December 9, 2024
Cost-effectiveness of the adjuvanted RSVPreF3 vaccine among adults aged ≥60 years in the United StatesElizabeth M La, Jonathan Graham, David Singer, et al.
Infectious Diseases and Therapy|March 20, 2024
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United StatesDaniel Molnar, Elizabeth M La, Frederik Verelst, et al.
Proteins|September 21, 2021
GABA receptor associated protein changes the electrostatic environment around the GABA type A receptorBenedict W J Irwin, Clara C Wanjura, Daniel Molnar, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 12, 2022
A Novel MATLAB®-Algorithm-Based Video Analysis to Quantitatively Determine Solution Creeping in Intact Pharmaceutical Glass VialsDaniel Molnar, Martina Röhm, Johannes Wutz, et al.
Pharmaceutics|February 26, 2022
Adalimumab Decorated Nanoparticles Enhance Antibody Stability and Therapeutic Outcome in Epithelial Colitis TargetingMarkus Ries, Brice Moulari, Maryam A Shetab Boushehri, et al.
Human Vaccines & Immunotherapeutics|October 25, 2019
Assessing direct and indirect effects of pediatric influenza vaccination in Germany by individual-based simulationsRuprecht Schmidt-Ott, Daniel Molnar, Anastassia Anastassopoulou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 6, 2026
Health-related quality of life in European older adults with respiratory syncytial virus over three respiratory syncytial virus seasonsManel Terns Riera, Rosa Prato, Alberto Pérez-Rubio, et al.
Journal of Market Access & Health Policy|August 16, 2023
Rule of Prevention: a potential framework to evaluate preventive interventions for rare diseasesEddie Gibson, Daniel A Ollendorf, Steven Simoens, et al.
Respiratory Investigation|August 10, 2024
Burden of respiratory syncytial virus infections in older adults with acute respiratory infection in Japan: An epidemiological study among outpatientsHiroyuki Ohbayashi, Takayuki Sakurai, Daisuke Himeji, et al.
Human Vaccines & Immunotherapeutics|April 29, 2022
Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in GermanyDaniel Molnar, Anastassia Anastassopoulou, Barbara Poulsen Nautrup, et al.
Pageof 3